NewcelX NCEL
NASDAQ NCEL
$2.97 +0.05 (+1.71%)
As of: Sep 29, 2026 · 3:59 PM EDT

NewcelX (NCEL) Receivables (2019 - 2025)

Updated

NewcelX's Receivables came in at $592,690 for Q2 2025, up 13.0% from $524,568 a year earlier.

Analysis

NewcelX (NCEL) Receivables (2019 - 2025) Analysis & Trends

At the end of FY2024, NewcelX's Receivables was $530,000, up 14.8% from FY2023.

  • Receivables carries a five-year compound annual growth rate of 50.8% (FY2019 to FY2024).
  • Going back by year, Receivables was $461,664 in FY2023 (+58.1%), $292,000 in FY2022 and $135,908 in FY2020 (+100.1%).
  • The Q2 2025 figure represents the highest quarterly Receivables in data going back to Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 NewcelX 11.22 Mn 11.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 592,690.00
Dec 31, 2024 530,000.00
Jun 30, 2024 524,568.00
Dec 31, 2023 461,664.00
Jun 30, 2023 399,000.00
Dec 31, 2022 292,000.00
Dec 31, 2020 135,908.00
Dec 31, 2019 67,904.00
API Access

NewcelX Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=NCEL&period=max&api_key=YOUR_API_KEY